Latest Articles
- Editor's CornerIdentifying targets for diagnosis, prognosis, and treatmentJosep DalmauApril 02, 2015
- Clinical/Scientific NotesGlial Cells Express Nuclear Nrf2 After Fumarate Treatment for Multiple Sclerosis and PsoriasisImke Metz, Sarah Traffehn, Katrin Straßburger-Krogias, et al.April 02, 2015
- ArticleThe growing spectrum of antibody-associated inflammatory brain diseases in childrenSandra Bigi, Manisha Hladio, Marinka Twilt, et al.April 02, 2015
- ArticleClinical course and treatment of anti-HMGCR antibody–associated necrotizing autoimmune myopathySudarshini Ramanathan, Daman Langguth, Todd A. Hardy, et al.April 02, 2015
- ArticleP2Y12 expression and function in alternatively activated human microgliaCraig S. Moore, Ariel R. Ase, Angham Kinsara, et al.March 19, 2015
- ArticleMOG cell-based assay detects non-MS patients with inflammatory neurologic diseasePatrick Waters, Mark Woodhall, Kevin C. O'Connor, et al.March 19, 2015
- Clinical/Scientific NotesA 41-year-old woman with acute weakness and encephalopathy associated with MOG antibodiesKatrina A. Morris, Paddy Waters, Mark R. Woodhall, et al.March 19, 2015
- EditorialIs intrathecal anti-CD20 an option to target compartmentalized CNS inflammation in progressive MS?Martin S. WeberMarch 12, 2015
- ArticleMyelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in childrenYael Hacohen, Michael Absoud, Kumaran Deiva, et al.March 12, 2015
Pages
Advertisement